Does ADALIMUMAB Cause Injection site discolouration? 554 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 554 reports of Injection site discolouration have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.1% of all adverse event reports for ADALIMUMAB.
554
Reports of Injection site discolouration with ADALIMUMAB
0.1%
of all ADALIMUMAB reports
0
Deaths
41
Hospitalizations
How Dangerous Is Injection site discolouration From ADALIMUMAB?
Of the 554 reports, 41 (7.4%) required hospitalization.
Is Injection site discolouration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 554 reports have been filed with the FAERS database.
What Other Side Effects Does ADALIMUMAB Cause?
Drug ineffective (71,926)
Pain (37,514)
Arthralgia (35,592)
Rheumatoid arthritis (29,817)
Fatigue (29,420)
Injection site pain (28,679)
Headache (19,891)
Nausea (19,299)
Rash (18,690)
Pain in extremity (18,319)
What Other Drugs Cause Injection site discolouration?
ETANERCEPT (1,846)
DUPILUMAB (779)
CERTOLIZUMAB PEGOL (597)
EVOLOCUMAB (476)
GLATIRAMER (270)
EXENATIDE (266)
TERIPARATIDE (249)
ASFOTASE ALFA (243)
ENBREL (231)
INSULIN GLARGINE (169)
Which ADALIMUMAB Alternatives Have Lower Injection site discolouration Risk?
ADALIMUMAB vs ADALIMUMAB-AACF
ADALIMUMAB vs ADALIMUMAB-AATY
ADALIMUMAB vs ADALIMUMAB-ADAZ
ADALIMUMAB vs ADALIMUMAB-ADBM
ADALIMUMAB vs ADALIMUMAB-AFZB